Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padmaja Chiruvolu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|October 21, 2014
Evaluation of statistical methods for safety signal detection: a simulation studyMaggie Chen, Li Zhu, Padmaja Chiruvolu, et al.
Journal of Lipid Research|June 13, 2026
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleFrederick J Raal, Robert P Giugliano, Marc S Sabatine, et al.
Journal of Lipid Research|April 23, 2016
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleFrederick J Raal, Robert P Giugliano, Marc S Sabatine, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|October 21, 2014
Evaluation of statistical methods for safety signal detection: a simulation studyMaggie Chen, Li Zhu, Padmaja Chiruvolu, et al.
Journal of Lipid Research|June 13, 2026
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleFrederick J Raal, Robert P Giugliano, Marc S Sabatine, et al.
Journal of Lipid Research|April 23, 2016
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleFrederick J Raal, Robert P Giugliano, Marc S Sabatine, et al.
Pageof 1